Literature DB >> 24623766

Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of ΔFosB.

Vincent Vialou1, Rosemary C Bagot, Michael E Cahill, Deveroux Ferguson, Alfred J Robison, David M Dietz, Barbara Fallon, Michelle Mazei-Robison, Stacy M Ku, Eileen Harrigan, Catherine A Winstanley, Tej Joshi, Jian Feng, Olivier Berton, Eric J Nestler.   

Abstract

Decreased medial prefrontal cortex (mPFC) neuronal activity is associated with social defeat-induced depression- and anxiety-like behaviors in mice. However, the molecular mechanisms underlying the decreased mPFC activity and its prodepressant role remain unknown. We show here that induction of the transcription factor ΔFosB in mPFC, specifically in the prelimbic (PrL) area, mediates susceptibility to stress. ΔFosB induction in PrL occurred selectively in susceptible mice after chronic social defeat stress, and overexpression of ΔFosB in this region, but not in the nearby infralimbic (IL) area, enhanced stress susceptibility. ΔFosB produced these effects partly through induction of the cholecystokinin (CCK)-B receptor: CCKB blockade in mPFC induces a resilient phenotype, whereas CCK administration into mPFC mimics the anxiogenic- and depressant-like effects of social stress. We previously found that optogenetic stimulation of mPFC neurons in susceptible mice reverses several behavioral abnormalities seen after chronic social defeat stress. Therefore, we hypothesized that optogenetic stimulation of cortical projections would rescue the pathological effects of CCK in mPFC. After CCK infusion in mPFC, we optogenetically stimulated mPFC projections to basolateral amygdala or nucleus accumbens, two subcortical structures involved in mood regulation. Stimulation of corticoamygdala projections blocked the anxiogenic effect of CCK, although no effect was observed on other symptoms of social defeat. Conversely, stimulation of corticoaccumbens projections reversed CCK-induced social avoidance and sucrose preference deficits but not anxiogenic-like effects. Together, these results indicate that social stress-induced behavioral deficits are mediated partly by molecular adaptations in mPFC involving ΔFosB and CCK through cortical projections to distinct subcortical targets.

Entities:  

Keywords:  CCK; accumbens; amygdala; anxiety; depression; mPFC

Mesh:

Substances:

Year:  2014        PMID: 24623766      PMCID: PMC3951691          DOI: 10.1523/JNEUROSCI.1787-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  72 in total

1.  DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses.

Authors:  Vincent Vialou; Alfred J Robison; Quincey C Laplant; Herbert E Covington; David M Dietz; Yoshinori N Ohnishi; Ezekiell Mouzon; Augustus J Rush; Emily L Watts; Deanna L Wallace; Sergio D Iñiguez; Yoko H Ohnishi; Michel A Steiner; Brandon L Warren; Vaishnav Krishnan; Carlos A Bolaños; Rachael L Neve; Subroto Ghose; Olivier Berton; Carol A Tamminga; Eric J Nestler
Journal:  Nat Neurosci       Date:  2010-05-16       Impact factor: 24.884

2.  Cholecystokinin and GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety.

Authors:  Mehdi Rezayat; Ali Roohbakhsh; Mohammad-Reza Zarrindast; Roohollah Massoudi; Bijan Djahanguiri
Journal:  Physiol Behav       Date:  2005-04-14

3.  Neurons in medial prefrontal cortex signal memory for fear extinction.

Authors:  Mohammed R Milad; Gregory J Quirk
Journal:  Nature       Date:  2002-11-07       Impact factor: 49.962

4.  Topographically specific hippocampal projections target functionally distinct prefrontal areas in the rhesus monkey.

Authors:  H Barbas; G J Blatt
Journal:  Hippocampus       Date:  1995       Impact factor: 3.899

5.  Regulation of gene expression and cocaine reward by CREB and DeltaFosB.

Authors:  Colleen A McClung; Eric J Nestler
Journal:  Nat Neurosci       Date:  2003-10-19       Impact factor: 24.884

6.  Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin.

Authors:  C Becker; B Zeau; C Rivat; A Blugeot; M Hamon; J-J Benoliel
Journal:  Mol Psychiatry       Date:  2007-09-25       Impact factor: 15.992

7.  Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala.

Authors:  I Belcheva; S Belcheva; V V Petkov; V D Petkov
Journal:  Neuropharmacology       Date:  1994-08       Impact factor: 5.250

8.  Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas.

Authors:  M Pérez de la Mora; A M Hernandez-Gómez; J Méndez-Franco; K Fuxe
Journal:  Eur J Pharmacol       Date:  1993-12-21       Impact factor: 4.432

Review 9.  Traumatic stress: effects on the brain.

Authors:  J Douglas Bremner
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

10.  Prelimbic BDNF and TrkB signaling regulates consolidation of both appetitive and aversive emotional learning.

Authors:  D C Choi; S L Gourley; K J Ressler
Journal:  Transl Psychiatry       Date:  2012-12-18       Impact factor: 6.222

View more
  121 in total

1.  Chemogenetic Excitation of Accumbens-Projecting Infralimbic Cortical Neurons Blocks Toluene-Induced Conditioned Place Preference.

Authors:  Wesley N Wayman; John J Woodward
Journal:  J Neurosci       Date:  2018-01-09       Impact factor: 6.167

2.  Comparison of the VTA and LC response to methylphenidate: a concomitant behavioral and neuronal study of adolescent male rats.

Authors:  Tahseen J Karim; Cruz Reyes-Vazquez; Nachum Dafny
Journal:  J Neurophysiol       Date:  2017-06-14       Impact factor: 2.714

3.  Antidepressant action of HDAC inhibition in the prefrontal cortex.

Authors:  H E Covington; I Maze; V Vialou; E J Nestler
Journal:  Neuroscience       Date:  2015-04-20       Impact factor: 3.590

4.  EphB2 in the Medial Prefrontal Cortex Regulates Vulnerability to Stress.

Authors:  Ruo-Xi Zhang; Ying Han; Chen Chen; Ling-Zhi Xu; Jia-Li Li; Na Chen; Cheng-Yu Sun; Wen-Hao Chen; Wei-Li Zhu; Jie Shi; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2016-04-22       Impact factor: 7.853

5.  VIPergic neurons of the infralimbic and prelimbic cortices control palatable food intake through separate cognitive pathways.

Authors:  Brandon A Newmyer; Ciarra M Whindleton; Peter M Klein; Mark P Beenhakker; Marieke K Jones; Michael M Scott
Journal:  JCI Insight       Date:  2019-04-02

Review 6.  Wiring the depressed brain: optogenetic and chemogenetic circuit interrogation in animal models of depression.

Authors:  Jessie Muir; Joëlle Lopez; Rosemary C Bagot
Journal:  Neuropsychopharmacology       Date:  2018-12-05       Impact factor: 7.853

7.  Chronic Stress Prevents Cortico-Accumbens Cue Encoding and Alters Conditioned Approach.

Authors:  Mitchell G Spring; Aaron Caccamise; Elizabeth A Panther; Bethany M Windsor; Karan R Soni; Jayme R McReynolds; Daniel S Wheeler; John R Mantsch; Robert A Wheeler
Journal:  J Neurosci       Date:  2021-02-23       Impact factor: 6.167

8.  Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior.

Authors:  Rebecca A Brachman; Josephine C McGowan; Jennifer N Perusini; Sean C Lim; Thu Ha Pham; Charlene Faye; Alain M Gardier; Indira Mendez-David; Denis J David; René Hen; Christine A Denny
Journal:  Biol Psychiatry       Date:  2015-05-04       Impact factor: 13.382

9.  Social Dominance Modulates Stress-induced Neural Activity in Medial Prefrontal Cortex Projections to the Basolateral Amygdala.

Authors:  Brooke N Dulka; Kimberly S Bress; J Alex Grizzell; Matthew A Cooper
Journal:  Neuroscience       Date:  2018-08-01       Impact factor: 3.590

10.  Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles.

Authors:  Rosemary C Bagot; Hannah M Cates; Immanuel Purushothaman; Vincent Vialou; Elizabeth A Heller; Lynn Yieh; Benoit LaBonté; Catherine J Peña; Li Shen; Gayle M Wittenberg; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2016-06-18       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.